when was semaglutide patented Last week's expiry of the patent for semaglutide—the active ingredient in Novo Nordisk's blockbuster drugs that are used to treat both diabetes and obesity—unleashed a flurry of launches of low-cost generic versions Off-patent semaglutide in 2026: the

Understanding when and how to adjust frequency helps you get the most from long-term treatment

High versus low VitE diets ad libitum was provided to animals either before or after tumor initiation (Fig

Circulating levels of endothelial progenitor cells are associated with better cognitive function in older adults with glucagon-like peptide 1 receptor agonist-treated type 2 diabetes

International Journal of Trichology , 9(3), 129134

If you have private or employer insurance: Most commercial insurance plans still cover GLP-1 medications for weight loss, though the specific drugs covered and the out-of-pocket costs can vary

Supplier disputes warning on TMAO Lonza, a major supplier of L-carnitine in the form of its Carnipure ingredient, disputed the dire nature of the researchers warnings about TMAO, noting that its ingredient has been used in supplements for years without ill effects